Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2019-08-09 | 2019-06-28 |
| Drug Identification Number | 02193221 | 02193221 |
| Brand name | THIAMIJECT INJECTION - LIQ IM IV 100MG/ML | THIAMIJECT INJECTION - LIQ IM IV 100MG/ML |
| Common or Proper name | Thiamine Hydrochloride Injection USP | Thiamine Hydrochloride Injection USP |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | THIAMINE HYDROCHLORIDE | THIAMINE HYDROCHLORIDE |
| Strength(s) | 100MG | 100MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAMUSCULAR INTRAVENOUS | INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 5 x 10mL vial / fiole | 5 x 10mL vial / fiole |
| ATC code | A11DA | A11DA |
| ATC description | VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12 | VIT B1,PLAIN AND IN COMB WITH VITAMIN B6 AND B12 |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2019-06-28 | 2019-06-28 |
| Estimated end date | 2019-08-05 | 2019-07-31 |
| Actual end date | 2019-08-02 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |